Cotinga Pharmaceuticals Ret. on assets
What is the Ret. on assets of Cotinga Pharmaceuticals?
The Ret. on assets of Cotinga Pharmaceuticals, Inc. is -119.87%
What is the definition of Ret. on assets?
Return on assets indicates how profitable a company’s assets are in generating revenue. It is computed by dividing net income by average total assets.
ttm (trailing twelve months)
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
Ret. on assets of companies in the Health Care sector on TSXV compared to Cotinga Pharmaceuticals
What does Cotinga Pharmaceuticals do?
Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada.
Companies with ret. on assets similar to Cotinga Pharmaceuticals
- Ziptel has Ret. on assets of -120.07%
- The Planting Hope Inc has Ret. on assets of -120.07%
- San Marco Resources has Ret. on assets of -120.06%
- Hazer has Ret. on assets of -119.95%
- Resource Mining has Ret. on assets of -119.93%
- Baselode has Ret. on assets of -119.91%
- Cotinga Pharmaceuticals has Ret. on assets of -119.87%
- Antalis Ventures has Ret. on assets of -119.61%
- Liquid Media has Ret. on assets of -119.58%
- Bionano Genomics Inc has Ret. on assets of -119.42%
- Shine Box Capital has Ret. on assets of -119.37%
- Tonix Pharmaceuticals Corp has Ret. on assets of -119.36%
- Respiri has Ret. on assets of -119.20%